About Todyindia
Todyindia is a Healthcare company based in Mumbai (India) founded in 2002. Imports and exports pharmaceutical APIs, excipients, nutraceuticals, and sweeteners worldwide. It operates on a B2B model in Healthcare and Agriculture sectors. Its Indian entity Nandlal Bankatlal Private Limited reported revenue of ₹127 Cr. Todyindia offers products and services including Acesulfame K, Sucralose, Vitamin A Palmitate, Vitamin B2 Riboflavin, and Doxycycline HCL. Its focus areas include Pharmaceuticals, APIs and Excipients, Nutraceuticals and Food and Agriculture Tech. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Nandlal Bankatlal Pvt. Ltd. operates as an importer and exporter of APIs, excipients, nutraceuticals, and sweeteners, sourcing from manufacturers in Germany, China, India, and Korea. The company supplies these products to customers in India, Sri Lanka, Nepal, UAE, and Africa through business partnerships. Based in Mumbai, India, it focuses on wholesale distribution in the pharmaceutical and chemical sectors, ensuring reliable supply chain logistics.
- Headquarters Mumbai, India
- SectorsHealthcareAgriculture
- Email••••••••
- Website todyindia.com
- Social LinkedIn X Facebook
- Legal Name Nandlal Bankatlal Private Limited
- Date of Incorporation 29 Jun, 1993
- Jurisdiction Daman, Daman and Diu, India
- Annual Revenue₹127 Cr
FY 2025 · -17% YoY
- Net Profit₹8.50 Cr
FY 2025 · 7% margin
- EBITDA₹12.34 Cr
FY 2025 · 10% margin
Associated legal entities of Todyindia
Todyindia operates through Nandlal Bankatlal Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nandlal Bankatlal Private Limited CIN U24232DD1993PTC001384 | Active | 29 Jun 1993 | Daman, Daman and Diu | ₹127 Cr | 3 | View details |
Products & Services of Todyindia
Todyindia offers a comprehensive portfolio of products and services, including Acesulfame K, Sucralose, Vitamin A Palmitate, Vitamin B2 Riboflavin, and Doxycycline HCL.
Calorie-free sugar substitute used in food and beverages
Non-nutritive sweetener that is not metabolized by the body
Ester of retinol and palmitic acid for nutritional supplements
Component of B vitamins for energy metabolism
Antibiotic used to treat bacterial infections
Vitamin B5 for metabolic and health functions
Functional sugar alcohol used in pharmaceutical formulations
Board of directors of Nandlal Bankatlal Private Limited (Todyindia)
Nandlal Bankatlal Private Limited is the primary company behind Todyindia. The board of Nandlal Bankatlal Private Limited currently have 3 directors; the longest-serving is Akhil Bankatlal Tody, appointed in 1993. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Akhil Bankatlal Tody DIN 00468019 | Managing Director | 29 Jun 1993 | 33 yrs 4 mo | Nandlal Bankatlal Private Limited |
| Deepika Akhil Tody DIN 00474996 | Whole-time director | 18 Dec 2002 | 23 yrs 10 mo | Nandlal Bankatlal Private Limited |
| Rishi Shroff DIN 05230770 | Director | 28 Nov 2023 | 2 yrs 11 mo | Nandlal Bankatlal Private Limited |
People of Todyindia
1 people are tracked at Todyindia (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Owner | Leadership |
Complete people profiles for Todyindia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Todyindia
Figures of Nandlal Bankatlal Private Limited, the primary company behind Todyindia, for FY 2025. Revenue was ₹127 Cr (-17% year on year). Net profit was ₹8.50 Cr (7% margin). EBITDA was ₹12.34 Cr (10% margin). Revenue has grown at a compounded annual rate of -5% over three years and +1% over five years.
- ₹127 CrRevenue · FY 2025 · -17% YoY
- ₹8.50 CrNet profit · 7% margin
- ₹12.34 CrEBITDA · 10% margin
- ₹24.5 LakhPaid-up capital
- -5%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nandlal Bankatlal Private Limited are on its company page.
Detailed financial statements for Todyindia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Todyindia
Todyindia has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Todyindia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Todyindia
Websites that share an audience with Todyindia (todyindia.com).
Websites whose visitors overlap most with Todyindia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
sinochemyangzhou.com | sinochemyangzhou.com | 100% | – | ||
| decachimie.com | 100% | #13,090,746 | View details | ||
rainbowchemicals.com | rainbowchemicals.com | 100% | – | ||
yanshanchem.com | yanshanchem.com | 100% | – | ||
greatearthchemical.com | greatearthchemical.com | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Todyindia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Todyindia (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 55.41 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 56.21 M | 144 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Todyindia
Todyindia was founded in 2002.
Todyindia is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Todyindia, Nandlal Bankatlal Private Limited, reported revenue of ₹127 Cr for FY 2025, down 17% year on year.
Nandlal Bankatlal Pvt. Ltd. operates as an importer and exporter of APIs, excipients, nutraceuticals, and sweeteners, sourcing from manufacturers in Germany, China, India, and Korea. The company supplies these products to customers in India, Sri Lanka, Nepal, UAE, and Africa through business partnerships. Based in Mumbai, India, it focuses on wholesale distribution in the pharmaceutical and chemical sectors, ensuring reliable supply chain logistics.
Todyindia's top competitors include Laurus Labs, Symbiotec and SeQuent.
Todyindia offers Acesulfame K, Sucralose, Vitamin A Palmitate, Vitamin B2 Riboflavin, and 3 more products and services.
Todyindia operates through Nandlal Bankatlal Private Limited.
The legal entities of Todyindia currently have 3 directors, including Rishi Shroff, Akhil Bankatlal Tody, Deepika Akhil Tody.